• news.cision.com/
  • Attana/
  • Information about Attana's presentation at Erik Penser Bank's theme day on September 16 at 12.55

Information about Attana's presentation at Erik Penser Bank's theme day on September 16 at 12.55

Report this content

On Thursday, September 16 at 12.55 Attana will participate in Erik Penser Bank’s theme day for Life Science Tools where Attana’s CEO, Teodor Aastrup, will present the company and answer questions.

The presentation will be held in Swedish and will focus on how Attana delivers value to its clients within Life Science, which includes a customer success story. Attana’s Diagnostic platform and SARS-CoV-2 immunoassay will also be presented as well as the company’s plans going forward.

Preliminary outline:

  1. Attana in short
  2. Attana Life Science
    1. Customer success story
  3. Attana Diagnostics
    1. SARS-CoV-2 Immunoassay
  4. Next steps

The event is live streamed and can be viewed on Erik Penser Bank’s Youtube channel.

When: September 16 at 12.55

Where: Digital event accessed through this link

For more information, please contact:

Teodor Aastrup, CEO
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com




Documents & Links